0.0002
0.0000
(0.00%)
At close: January 31 at 3:00:00 PM EST
Breakdown
TTM
Operating Cash Flow
-264.3610
Financing Cash Flow
250.0000
End Cash Position
61.2700
Issuance of Debt
250.0000
Free Cash Flow
-264.3610
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
W1H.SG Onco-Innovations Ltd
1.3100
+2.34%
25K.F Karyopharm Therapeutics Inc.
0.6216
-1.24%
0N6A.MU TME Pharma NV
0.0752
0.00%
W1H.BE Onco-Innovations Ltd
1.3700
+6.20%
W1H.F Onco-Innovations Limited
1.3300
+2.31%
BETRF BetterLife Pharma Inc.
0.0890
0.00%
ANTH Anthera Pharmaceuticals, Inc.
0.0002
0.00%
ONCO.CN Onco-Innova
2.0400
+6.81%
VICO.ST Vicore Pharma Holding AB (publ)
9.09
-0.76%
OABIW OmniAb, Inc.
0.3950
+12.86%